Latest filing published 04 Nov 2026 for Gilead Sciences, INC., €16.7M.
Insider track record
Daniel O'Day: trading record in brief
Daniel O'Day is a declared insider of Gilead Sciences, Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 3 August 2026 to 4 November 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 4 November 2026, reports a transaction of €16.7M in Gilead Sciences, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Daniel O'Day
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 112,429 shares@ US$167.47CommonSEC144:0001950047-26-010699
- 45,881 shares@ US$165.610.0037% mcap52.2% of flowCommonSEC144:0001950047-26-010512
- 55,000 shares@ US$130.210.0038% mcap100.0% of flowCommonSEC144:0001950047-26-007556
3 of 3 declarations
